Two male patients with ankylosing spondylitis and upper lobe fibrosis and cavitation are described. A pneumonic disease in one was associated with mycological and serological evidence of infection with Aspergillus terreus but no other aspergillus species. A large pulmonary mycetoma developed in the second patient and among a number of other fungal isolates was found the yeast Metschnikowia pulcherrima. The association of ankylosing spondylitis with bronchopulmonary aspergillosis is considered; A. terreus is described for the first time as a human pulmonary pathogen, and the possible pathogenicity of M. pulcherrima in the debilitated human subject is discussed.
Two male patients with ankylosing spondylitis and upper lobe fibrosis and cavitation are described. A pneumonic disease in one was associated with mycological and serological evidence of infection with Aspergillus terreus but no other aspergillus species. A large pulmonary mycetoma developed in the second patient and among a number of other fungal isolates was found the yeast Metschnikowia pulcherrima. The association of ankylosing spondylitis with bronchopulmonary aspergillosis is considered; A. terreus is described for the first time as a human pulmonary pathogen, and the possible pathogenicity of M. pulcherrima in the debilitated human subject is discussed.
Aspergillus fumigatus is the fungal organism most commonly productive of pulmonary disease in this country, but a number of other Aspergillus species have, from time to time, been recognized as pathogenic to man. Aspergillus terreus, however, has infrequently been recorded in human disease and seems rarely, if at all, to have been suspected as a respiratory pathogen. Nor, to our knowledge, has the yeast Metschnikowia pulcherrima (previously Candida pulcherrima) been implicated in human pulmonary infection.
Two patients are described, each with longstanding ankylosing spondylitis. Pulmonary changes were present in both, characterized by fibrosis and cavitation in the upper lobes. The first patient showed evidence of infection with A. terreus. The second developed an A. fumigatus mycetoma, and M. pulcherrima was isolated from a number of sources. (Fig. 1) . He was admitted to hospital for treatment and for investigation of the possibility of pulmonary aspergillosis. His haemoglobin was 11-6 g/100 ml, white cell count 6,900/ mm3, and ESR 116 mm in the first hour. Clinical recovery was satisfactory, without antibiotic therapy, and the radiographic abnormalities in the lower zones cleared. A. terreus was still present in the sputum, however. Following discharge from hospital he was seen at monthly intervals and remained well. On each occasion the sputum was examined mycologically and yielded profuse growths of A. terreus. Six months after discharge skin tests were carried out by the prick method, using both proprietary solutions and an extract of broth culture fluid of the patient's own organism. Dermal sensitivity to A. terreus was demonstrated whereas there was no reaction to A. fumigatus (Table) . He was most recently seen nine months after discharge when he was well and his sputum, for the first time, showed absence of fungal growth.
PATIENT 2 A 43-year-old man was admitted to hospital with a two-month history of malaise, anorexia, Necropsy findings Much of the right pleural sac was obliterated by old fibrous adhesions. The upper lobe of the right lung contained a cavity 12-5 cm in diameter within which was a solid spherical mycetoma measuring 2-5 cm in diameter (Fig. 4) A randomly distributed background flora of filamentous fungi included penicillia (P. lanioso-viride, P. herquei, P. tardum, and P. decumbens), aspergilli (A. ustus, A. versicolor, and A. niger), Ostracoderma sp., and Botrytis cinerea. Urine M. pulcherrima was recovered from two samples, R. glutinis from two, and A. fumnigatus from one.
Stool Candida tropicalis was the sole fungus isolated; blastospores were common in smears. Blood All samples were negative for fungi.
During the second month of sampling A. fumigatus was not cultured from the sputum although on one occasion dichotomously branched hyphae were seen in smears. A. fumigatus occurred only twice in urine cultures. Stools gave a consistently high yield of C. tropicalis and smears showed numerous blastospores. At necropsy settle plates of malt agar exposed adjacent to the cadaver gave colonies of Cladosporium sp. A. fumigatus was cultured from the mycetoma and from the lower lobe of the left lung. Blood which remained in the thorax after dissection gave colonies of M. pulcherrima and Cladosporium sp. C. albicans and M. pulcherrima were isolated from the thrombus in the superior vena cava. A. fumigatus was also recovered from the cortex of the right kidney. Two unusual organisms associated with the lung disease of ankylosing spondylitis DISCUSSION The concurrence of ankylosing spondylitis and pulmonary aspergillosis may well have been fortuitous in the two patients described. Certain changes, however, may occur in the lungs in the presence of long-standing ankylosing spondylitis, and if cavitation develops there is an ideal site for colonization by fungi with airborne spores. There is a recognized association between ankylosing spondylitis and an increased incidence of pulmonary tuberculosis (Crofton and Douglas, 1969) . Aspergillus species will colonize a significant proportion of residual tuberculous cavities, as has been shown by large-scale investigations (British Tuberculosis Association, 1968) . Furthermore, attention has recently been drawn to a specific infiltrative and fibrosing lesion in the lungs of patients with ankylosing spondylitis, in which cyst formation occurs in the affected upper lobes (British Medical Journal, 1971 ). Davies (1971) has referred to a figure of over 50 reported cases. Pulmonary damage may also result from intensive midline irradiation for spinal disease.
Of the few patients in whom ankylosing spondylitis has been recorded as accompanying pulmonary mycetoma formation, that of Campbell and Clayton (1964) and that of Edwards and La Touche (1964) are noted also to have had bronchiectasis, perhaps secondary to irradiation damage. Five patients with pulmonary mycetoma and ankylosing spondylitis were reported by Krohn and Halvorsen (1968) , but no details of radiotherapy were given. Leggat and de Kretser (1968) reported the development of an aspergilloma in a patient who had received radiotherapy for ankylosing spondylitis and who had fibrotic changes in both upper lobes. A mycetoma due to Allescheria boydii has been recorded in a patient with advanced ankylosing spondylitis; details of radiotherapy were not given (Adelson and Malcolm, 1968) .
In a survey of patients with lung cavitation and fibrosis mimicking tuberculosis, Davies (1970) described four patients with ankylosing spondylitis having the specific upper lobe changes previously alluded to, all of whom developed unilateral or bilateral aspergillomata. One of these four was the patient reported by Leggat and de Kretser (1968) . It seems probable that our own two patients are further examples of this specific pulmonary lesion in ankylosing spondylitis.
A. terreus is one of the most common and widely distributed of soil organisms. It is charac-2X terized by strongly columnar cinnamon to orange-brown conidial heads (Raper and Fennell, 1965) . Although it is known to be a potential pathogen, its importance as such has previously been confined to superficial infections of the skin, nails, and external ear (English and Dalton, 1962; English, 1963; Austwick, 1965) . Mahgoub, Ismail, and El Hassan (1969) have reported one proven case of human cervical lymphadenitis caused by A. terreus in the Sudan. In the animal sphere, it may be a cause of bovine mycotic abortion (Ainsworth and Austwick, 1959) . It has also been isolated from a granulomatous skin lesion in a cow (Davis and Schaefer, 1962) . Pore and Larsh (1968) have shown it to produce neurological and renal lesions in inoculated mice. Pathogenic activity of A. terreus in the human respiratory system has not previously been reported, although the organism has been obtained from pulmonary lesions in birds (Ainsworth and Austwick, 1955) .
M. pulcherrima, a yeast previously named C. pulcherrima, was first isolated by Lindner in 1901. The organism is distinguishable from other yeasts by the presence of globose 'pulcherrima' cells containing a single large lipid globule (Lodder, 1970) . It also elaborates a red pigment known as pulcherrimin. It is geographically widely distributed, usually being found on fruits, flowers, and other vegetable material. Ainsworth and Austwick (1959) listed the organism among a number of 'isolates of uncertain status' as a possible causative agent in mycotic mastitis in animals. There is little mention of this yeast in the literature on human disease but Lodder and Kreger-van Rij (1952) quote two instances of its isolation from human subjects-one strain from interdigital skin lesions (Poilaci and Nannizzi, 1926) and two strains from the oropharyngeal regions of normal or diseased persons (Orie, 1946) .
Although the examination of the two patients described in this paper may have shed little further light on the association of bronchopulmonary aspergillosis with ankylosing spondylitis, it has brought to notice the potential pathogenicity of two fungal organisms not previously implicated in infection of the human respiratory tract. A. terreus was consistently isolated from the sputum of the first patient over a period of six months, and he was shown to have developed both reaginic and precipitating antibodies to this organism. The second patient had a large mycetoma caused by A. fumigatus, but among an assemblage of other less prominent fungal iso-609 group.bmj.com on June 25, 2017 -Published by http://thorax.bmj.com/ Downloaded from lates was the yeast M. pulcherrima, which occurred in sputum and urine during life, and also in post-mortem superior vena caval thrombus. M. pulcherrima could not justifiably be termed a pathogen on the present evidence and was probably no more than a secondary invader, but these observations do draw attention to it as a possible infecting organism in the debilitated human subject.
